Further Outpatient Care

Postsubmacular surgery patients require a first postoperative day visit, followed by a 2- to 3-week visit. Thereafter, any time that the patient notes a change in the Amsler grid, a visit should be scheduled.

Further Inpatient Care

All medical and surgical treatments for choroidal neovascular membranes (CNVMs) can be performed in an outpatient setting.

Transfer

Retinal specialists should manage patients with CNVM.

Complications

Recurrent CNVMs occur in 25-50% of submacular surgery cases.

Cataracts occur frequently after vitreoretinal surgery.

Subretinal, suprachoroidal, and vitreous hemorrhage can occur after surgery.

Retinal detachment can occur after surgery.

Endophthalmitis can occur after any ocular surgery or intravitreal injection.

Steroid glaucoma occurs 20-30% of the time after intravitreal injection of Kenalog.

Prognosis

There is a 25-50% chance of recurrent CNVM after submacular surgery. Submacular hemorrhage is not uncommon after submacular surgery. Postoperative vision typically is limited by recurrences, damage to the RPE, and overlying retina.

Patient Education

Advise patients to use the Amsler grid to monitor their central fields daily.^[189]

For excellent patient education resources, visit eMedicineHealth's Eye and Vision Center. Also, see eMedicineHealth's patient education article Macular Degeneration.

la Cour M, Kiilgaard JF, Nissen MH. Age-related macular degeneration: epidemiology and optimal treatment. Drugs Aging. 2002. 19(2):101-33. [QxMD MEDLINE Link].
la Cour M, Nielsen NV, Larsen M, Haamann PH, Vinding T. [Age related macular degeneration. A widespread disease]. Ugeskr Laeger. 2001 Nov 12. 163(46):6396-400. [QxMD MEDLINE Link].
Verma L, Das T, Binder S, et al. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration. Indian J Ophthalmol. 2000 Dec. 48(4):263-78. [QxMD MEDLINE Link].
Venkatesh P, Gupta RK, Verma L, Tewari HK. Evaluation of trans-scleral diode laser using diopexy probe for subfoveal choroidal neovascular membrane in age-related macular degeneration. J Clin Laser Med Surg. 2004 Apr. 22(2):91-7. [QxMD MEDLINE Link].
Soubrane G, Souied E, Haddad W, et al. Alternative therapies for choroidal neovessels resulting from age-related macular degeneration [in French]. J Fr Ophtalmol. 2003 Oct. 26(8):876-8. [QxMD MEDLINE Link].
Soubrane G, Kuhn D, Oubraham H, Quaranta M, Coscas G. [New therapies for the treatment of age-related macular degeneration]. J Soc Biol. 2001. 195(2):115-8. [QxMD MEDLINE Link].
Sickenberg M. Early detection, diagnosis and management of choroidal neovascularization in age-related macular degeneration: the role of ophthalmologists. Ophthalmologica. 2001 Jul-Aug. 215(4):247-53. [QxMD MEDLINE Link].
Seland JH. [Age-related macular degeneration]. Tidsskr Nor Laegeforen. 2004 Jan 8. 124(1):52-4. [QxMD MEDLINE Link].
Rumelt S, Kaiserman I, Rehany U, Ophir A, Pikkel J, Loewenstein A. Detachment of subfoveal choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol. 2002 Dec. 134(6):822-7. [QxMD MEDLINE Link].
Razavi S, Coscas G, Soubrane G. [Age related macular degeneration: a review of anti-angiogenic treatments]. J Fr Ophtalmol. 2002 Sep. 25(7):747-52. [QxMD MEDLINE Link].
Potocky M, Trnavec B. [Etiopathogenesis of age-related macular degeneration and present possibilities of treatment]. Bratisl Lek Listy. 2000. 101(4):231-3. [QxMD MEDLINE Link].
Oneill C, Jamison J, McCulloch D, Smith D. Age-related macular degeneration: cost-of-illness issues. Drugs Aging. 2001. 18(4):233-41. [QxMD MEDLINE Link].
Mohan KC, Shukla D, Namperumalsamy P, Kim R. Management of age-related macular degeneration. J Indian Med Assoc. 2003 Aug. 101(8):471-4, 476. [QxMD MEDLINE Link].
Mittra RA, Singerman LJ. Recent advances in the management of age-related macular degeneration. Optom Vis Sci. 2002 Apr. 79(4):218-24. [QxMD MEDLINE Link].
Mittra RA. New treatments for age-related macular degeneration. Minn Med. 2003 Apr. 86(4):40-6. [QxMD MEDLINE Link].
La Heij EC, Liem AT, Hendrikse F. [Age-related macular degeneration; therapeutic options]. Ned Tijdschr Geneeskd. 2001 Jul 21. 145(29):1390-7. [QxMD MEDLINE Link].
Korner-Stiefbold U. [Age-related macular degeneration (AMD)--therapeutic possibilities and new approaches]. Ther Umsch. 2001 Jan. 58(1):28-35. [QxMD MEDLINE Link].
Koh AH, Ang CL. Age-related macular degeneration: what's new. Ann Acad Med Singapore. 2002 May. 31(3):399-404. [QxMD MEDLINE Link].
Hunt DW, Margaron P. Status of therapies in development for the treatment of age-related macular degeneration. IDrugs. 2003 May. 6(5):464-9. [QxMD MEDLINE Link].
Hooper CY, Guymer RH. New treatments in age-related macular degeneration. Clin Experiment Ophthalmol. 2003 Oct. 31(5):376-91. [QxMD MEDLINE Link].
Frennesson C, Nilsson SE. [Age-related macular degeneration--new possibilities for prophylactic measures]. Lakartidningen. 2002 Aug 8. 99(32-33):3194-7. [QxMD MEDLINE Link].
Fong DS. Age-related macular degeneration: update for primary care. Am Fam Physician. 2000 May 15. 61(10):3035-42. [QxMD MEDLINE Link].
Donati G. [Current treatment of choroidal neovascularization in age-related macular degeneration]. J Fr Ophtalmol. 2002 Sep. 25(7):740-6. [QxMD MEDLINE Link].
Donati G. [Treatment according to "evidence-based medicine" of aged-related exudative age-related macular degeneration (laser photocoagulation and photodynamic therapy)]. Klin Monbl Augenheilkd. 2001 May. 218(5):313-5. [QxMD MEDLINE Link].
Coscas F, Stanescu D, Coscas G, Soubrane G. [Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration]. J Fr Ophtalmol. 2003 Jun. 26(6):602-8. [QxMD MEDLINE Link].
Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol. 1998 Sep-Oct. 43(2):134-46. [QxMD MEDLINE Link].
Akduman L, Del Priore LV, Desai VN, Olk RJ, Kaplan HJ. Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1997 Jan. 123(1):90-6. [QxMD MEDLINE Link].
Parodi MB, Da Pozzo S, Ravalico G. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia. Br J Ophthalmol. 2003 Feb. 87(2):177-83. [QxMD MEDLINE Link].
Wang X, Hu S. [A review of research actuality on age-related macular degeneration]. Yan Ke Xue Bao. 2001 Dec. 17(4):245-51. [QxMD MEDLINE Link].
Korte GE, Reppucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984 Oct. 25(10):1135-45. [QxMD MEDLINE Link].
Kuwabara T, Ishikawa Y, Kaiser-Kupfer MI. Experimental model of gyrate atrophy in animals. Ophthalmology. 1981 Apr. 88(4):331-5. [QxMD MEDLINE Link].
Flower RW, von Kerczek C, Zhu L, Ernest A, Eggleton C, Topoleski LD. Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol. 2001 Jul. 132(1):85-93. [QxMD MEDLINE Link].
Del Priore LV, Kaplan HJ, Hornbeck R, Jones Z, Swinn M. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996 Nov. 122(5):629-43. [QxMD MEDLINE Link].
Apostol S. [Past, present, and future therapeutically options in age related macular degeneration]. Oftalmologia. 2002. 53(2):5-8. [QxMD MEDLINE Link].
Carstocea B, Gafencu O, Armegioiu M, et al. [Age related macular degeneration surgery]. Oftalmologia. 2002. 53(2):97-102. [QxMD MEDLINE Link].
Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol. 2002 Mar. 86(3):321-7. [QxMD MEDLINE Link].
Miskala PH, Hawkins BS, Mangione CM, et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. Arch Ophthalmol. 2003 Apr. 121(4):531-9. [QxMD MEDLINE Link].
Ergun E, Maar N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2003 Jan. 110(1):65-9. [QxMD MEDLINE Link].
Bermig J, Tylla H, Jochmann C, Nestler A, Wolf S. Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002 Mar. 240(3):169-75. [QxMD MEDLINE Link].
Torron Fernandez-Blanco C, Perez Olivan S, Melcon Sanchez-Friera B, Ferrer Novella E, Ruiz-Moreno O, Honrubia Lopez FM. [Dynamic angiography in age related macular degeneration]. Arch Soc Esp Oftalmol. 2002 Jul. 77(7):353-9. [QxMD MEDLINE Link].
Luke C, Aisenbrey S, Luke M, Marzella G, Bartz-Schmidt KU, Walter P. Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol. 2001 Aug. 85(8):928-32. [QxMD MEDLINE Link].
Luke C, Alteheld N, Aisenbrey S, et al. Electro-oculographic findings after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2003 Sep. 241(9):710-5. [QxMD MEDLINE Link].
Kaiser RS, Berger JW, Williams GA, et al. Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration. Retina. 2002 Dec. 22(6):683-90. [QxMD MEDLINE Link].
Cekiç O, Ohji M, KesercI B, et al. Evaluation of choroidal perfusion of the new central macular area by dilution analysis of indocyanine green angiography after macular translocation. Retina. 2004 Apr. 24(2):210-4. [QxMD MEDLINE Link].
Stoffelns BM. [Kinetics of indocyanine green (ICG) and clinical use for enhancement of transpupillary thermotherapy (TTT) in hypopigmented small choroidal melanomas]. Klin Monbl Augenheilkd. 2004 May. 221(5):374-8. [QxMD MEDLINE Link].
Kent DL, Fujii GY, Pieramici DJ, et al. Angiographic characteristics in patients undergoing macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Retina. 2003 Apr. 23(2):152-8. [QxMD MEDLINE Link].
Holz FG, Jorzik J, Schutt F, Flach U, Unnebrink K. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology. 2003 Feb. 110(2):400-5. [QxMD MEDLINE Link].
Haddad WM, Coscas G, Soubrane G. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration. Br J Ophthalmol. 2002 Jun. 86(6):663-9. [QxMD MEDLINE Link].
Farah ME, Cardillo JA, Luzardo AC, Calucci D, Williams GA, Costa RA. Indocyanine green mediated photothrombosis for the management of predominantly classic choroidal neovascularisation caused by age related macular degeneration. Br J Ophthalmol. 2004 Aug. 88(8):1055-9. [QxMD MEDLINE Link].
Montero JA, Ruiz-Moreno JM, Tavolato M. Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefes Arch Clin Exp Ophthalmol. 2003 Oct. 241(10):797-802. [QxMD MEDLINE Link].
Witkin AJ, Vuong LN, Srinivasan VJ, et al. High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration. Ophthalmology. 2009 May. 116(5):956-63. [QxMD MEDLINE Link]. [Full Text].
Bereczki A, Toth J, Suveges I. Histological examination of the pigment epithelium-Bruch membrane-chorio-capillaris complex after macular translocation. Br J Ophthalmol. 2000 May. 84(5):550-1. [QxMD MEDLINE Link].
Castellarin AA, Sugino IK, Nasir M, Zarbin MA. Clinicopathological correlation of an excised choroidal neovascular membrane in pseudotumour cerebri. Br J Ophthalmol. 1997 Nov. 81(11):994-1000. [QxMD MEDLINE Link].
Mozaffarieh M, Sacu S, Wedrich A. The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J. 2003 Dec 11. 2:20. [QxMD MEDLINE Link]. [Full Text].
Vadala M, Pece A, Cipolla S, et al. Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol. 2011 May. 95(5):657-61. [QxMD MEDLINE Link].
Mones JM, Amselem L, Serrano A, Garcia M, Hijano M. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye (Lond). 2009 Jun. 23(6):1275-80; quiz 1281. [QxMD MEDLINE Link].
Mitchell P, Korobelnik JF, Lanzetta P, et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol. 2009 May 20. [QxMD MEDLINE Link].
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5. 355(14):1419-31. [QxMD MEDLINE Link].
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5. 355(14):1432-44. [QxMD MEDLINE Link].
Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009 Jan. 116(1):57-65.e5. [QxMD MEDLINE Link].
Klein KS, Walsh MK, Hassan TS, et al. Endophthalmitis after anti-VEGF injections. Ophthalmology. 2009 Jun. 116(6):1225.e1. [QxMD MEDLINE Link].
Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1991 Jan 15. 111(1):1-7. [QxMD MEDLINE Link].
Schmidt JC, Rodrigues EB, Meyer CH, Kroll P. Is membrane extraction in cases of exudative age-related macular degeneration still up-to-date? A 4-year résumé. Ophthalmologica. 2003 Nov-Dec. 217(6):401-7. [QxMD MEDLINE Link].
Pollack JS, Del Priore LV, Smith ME, Feiner MA, Kaplan HJ. Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration. Br J Ophthalmol. 1996 Apr. 80(4):314-8. [QxMD MEDLINE Link]. [Full Text].
Castellarin AA, Nasir M, Sugino IK, Zarbin MA. Progressive presumed choriocapillaris atrophy after surgery for age-related macular degeneration. Retina. 1998. 18(2):143-9. [QxMD MEDLINE Link].
Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci. 1998 May. 39(6):1021-7. [QxMD MEDLINE Link].
Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1994 Dec. 232(12):707-16. [QxMD MEDLINE Link].
Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol. 1997 Mar. 235(3):149-58. [QxMD MEDLINE Link].
Aramant RB, Seiler MJ, Ball SL. Successful cotransplantation of intact sheets of fetal retina with retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1999 Jun. 40(7):1557-64. [QxMD MEDLINE Link].
Del Priore LV, Hornbeck R, Kaplan HJ, et al. Débridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol. 1995 Jul. 113(7):939-44. [QxMD MEDLINE Link].
Joussen AM. How complete is successful? "Autologous retinal pigment epithelium and choriod translocation in patients with exsudative age-related macular degeneration: a short-term follow-up" by Jan van Meurs and P.R. van Biesen. Graefes Arch Clin Exp Ophthalmol. 2003 Dec. 241(12):966-7. [QxMD MEDLINE Link].
Lane C, Boulton M, Marshall J. Transplantation of retinal pigment epithelium using a pars plana approach. Eye (Lond). 1989. 3 ( Pt 1):27-32. [QxMD MEDLINE Link].
Lappas A, Weinberger AW, Foerster AM, Kube T, Rezai KA, Kirchhof B. Iris pigment epithelial cell translocation in exudative age-related macular degeneration. A pilot study in patients. Graefes Arch Clin Exp Ophthalmol. 2000 Aug. 238(8):631-41. [QxMD MEDLINE Link].
Lavail MM, Li L, Turner JE, Yasumura D. Retinal pigment epithelial cell transplantation in RCS rats: normal metabolism in rescued photoreceptors. Exp Eye Res. 1992 Oct. 55(4):555-62. [QxMD MEDLINE Link].
Mueller-Jensen K, Machemer R, Azarnia R. Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber. Am J Ophthalmol. 1975 Sep. 80(3 Pt 2):530-7. [QxMD MEDLINE Link].
Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC Jr, Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991 Feb. 22(2):102-8. [QxMD MEDLINE Link].
Seaton AD, Turner JE. RPE transplants stabilize retinal vasculature and prevent neovascularization in the RCS rat. Invest Ophthalmol Vis Sci. 1992 Jan. 33(1):83-91. [QxMD MEDLINE Link].
Semkova I, Kreppel F, Welsandt G, et al. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad Sci U S A. 2002 Oct 1. 99(20):13090-5. [QxMD MEDLINE Link].
Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001. 23(4-6):297-307. [QxMD MEDLINE Link].
Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002 Aug. 109(8):1492-8. [QxMD MEDLINE Link].
van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003 Oct. 136(4):688-95. [QxMD MEDLINE Link].
Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004 Nov. 45(11):4151-60. [QxMD MEDLINE Link].
Valentino TL, Kaplan HJ, Del Priore LV, Fang SR, Berger A, Silverman MS. Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch Ophthalmol. 1995 Jul. 113(7):932-8. [QxMD MEDLINE Link].
Yamaguchi K, Yamaguchi K, Young RW, et al. Vitreoretinal surgical technique for transplanting retinal pigment epithelium in rabbit retina. Jpn J Ophthalmol. 1992. 36(2):142-50. [QxMD MEDLINE Link].
Mueller-Jensen K, Mandelcorn MS. Membrane formation by autotransplanted retinal pigment epithelium. Mod Probl Ophthalmol. 1975. 15:228-34.
Lappas A, Foerster AM, Weinberger AW, Coburger S, Schrage NF, Kirchhof B. Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol. 2004 Aug. 242(8):638-47. [QxMD MEDLINE Link].
Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 2003 May. 87(5):615-21. [QxMD MEDLINE Link].
Aisenbrey S, Bartz-Schmidt U. Macular translocation with 360-degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. 2003 May. 135(5):748-9; author reply 749. [QxMD MEDLINE Link].
Aisenbrey S, Lafaut B, Szurman P, et al. [Macular translocation with 360 degree retinotomy in the treatment if exudative macular degeneration. Functional and angiographic results]. Ophthalmologe. 2002 Mar. 99(3):164-70. [QxMD MEDLINE Link].
Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002 Apr. 120(4):451-9. [QxMD MEDLINE Link].
Akduman L, Karavellas MP, MacDonald JC, Olk RJ, Freeman WR. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. Retina. 1999. 19(5):418-23. [QxMD MEDLINE Link].
Albini TA, Rao NA, Li A, Craft CM, Fujii GY, De Juan E Jr. Limited macular translocation: a clinicopathologic case report. Ophthalmology. 2004 Jun. 111(6):1209-14. [QxMD MEDLINE Link].
American Academy of Ophthalmology. Macular translocation. American Academy of Ophthalmology. Ophthalmology. 2000 May. 107(5):1015-8. [QxMD MEDLINE Link].
Au Eong KG, Pieramici DJ, Fujii GY, et al. Macular translocation: unifying concepts, terminology, and classification. Am J Ophthalmol. 2001 Feb. 131(2):244-53. [QxMD MEDLINE Link].
Benner JD, Meyer CH, Shirkey BL, Toth CA. Macular translocation with radial scleral ouffolding: experimental studies and initial human results. Graefes Arch Clin Exp Ophthalmol. 2001 Nov. 239(11):815-23. [QxMD MEDLINE Link].
Benner JD, Sunness JS, Ziegler MD, Soltanian J. Limited macular translocation for atrophic maculopathy. Arch Ophthalmol. 2002 May. 120(5):586-91. [QxMD MEDLINE Link].
Cahill MT, Freedman SF, Toth CA. Macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol. 2003 Jan. 121(1):132-3. [QxMD MEDLINE Link].
Cekiç O, Keserci B, Ohji M, et al. Macular translocation surgery and retinal circulation times. Retina. 2004 Feb. 24(1):51-6. [QxMD MEDLINE Link].
Cekic O, Ohji M, Tano Y, Chang S. Continuous outflow devices for macular translocation with 360-degree retinotomy. Am J Ophthalmol. 2003 Feb. 135(2):241-3. [QxMD MEDLINE Link].
Chang AA, Tan W, Beaumont PE, Zeldovich A. Limited macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration. Clin Experiment Ophthalmol. 2003 Apr. 31(2):103-9. [QxMD MEDLINE Link].
D'Amico DJ, Friberg TR. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2001 Aug. 132(2):289-90. [QxMD MEDLINE Link].
Deramo VA, Meyer CH, Toth CA. Successful macular translocation with temporary scleral infolding using absorbable sture. Retina. 2001. 21(4):304-11. [QxMD MEDLINE Link].
Dolezalova J, Rusnak S. [Macular translocation--first experience]. Cesk Slov Oftalmol. 2004 Jul. 60(4):239-47. [QxMD MEDLINE Link].
Eckardt C, Eckardt U. Macular translocation in nonexudative age-related macular degeneration. Retina. 2002 Dec. 22(6):786-94. [QxMD MEDLINE Link].
Eckardt C, Eckardt U, Groos S, Luciano L, Reale E. Macular translocation in a patient with adult-onset foveomacular vitelliform dystrophy with light- and electron-microscopic observations on the surgically removed subfoveal tissue. Graefes Arch Clin Exp Ophthalmol. 2004 Jun. 242(6):456-67. [QxMD MEDLINE Link].
Fang X, Hayashi A, Morimoto T, et al. Retinal changes after macular translocation with 360-degree retinotomy in monkey eyes. Am J Ophthalmol. 2004 Jun. 137(6):1034-41. [QxMD MEDLINE Link].
Faude F, Wendt S, Biedermann B, et al. Facilitation of artificial retinal detachment for macular translocation surgery tested in rabbit. Invest Ophthalmol Vis Sci. 2001 May. 42(6):1328-37. [QxMD MEDLINE Link].
Faude F, Wiedemann P, Reichenbach A. A "detachment infusion" for macular translocation surgery. Retina. 1999. 19(2):173-4. [QxMD MEDLINE Link].
Fujii GY, Au Eong KG, Humayun MS, de Juan E Jr. Limited macular translocation: current concepts. Ophthalmol Clin North Am. 2002 Dec. 15(4):425-36. [QxMD MEDLINE Link].
Fujii GY, de Juan E Jr, Au Eong KG, Harlan JB Jr. Effective nasal limited macular translocation. Am J Ophthalmol. 2001 Jul. 132(1):124-6. [QxMD MEDLINE Link].
Fujii GY, de Juan E Jr, Humayun MS, Chang TS. Limited macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapy. Am J Ophthalmol. 2003 Jan. 135(1):109-12. [QxMD MEDLINE Link].
Fujii GY, de Juan E Jr, Pieramici DJ, et al. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol. 2002 Jul. 134(1):69-74. [QxMD MEDLINE Link].
Fujii GY, de Juan E Jr, Sunness J, Humayun MS, Pieramici DJ, Chang TS. Patient selection for macular translocation surgery using the scanning laser ophthalmoscope. Ophthalmology. 2002 Sep. 109(9):1737-44. [QxMD MEDLINE Link].
Fujii GY, de Juan E, Thomas MA, Pieramici DJ, Humayun MS, Au Eong KG. Limited macular translocation for the management of subfoveal retinal pigment epithelial loss after submacular surgery. Am J Ophthalmol. 2001 Feb. 131(2):272-5. [QxMD MEDLINE Link].
Fujii GY, Humayun MS, Pieramici DJ, Schachat AP, Au Eong KG, de Juan E Jr. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol. 2001 Jan. 131(1):90-100. [QxMD MEDLINE Link].
Glacet-Bernard A, Kuhn D, Coscas F, Coscas G, Soubrane G. [Translocation of the macula for retrofoveal choroidal neovascularization in age-related macular degeneration and severe myopia: first results]. J Fr Ophtalmol. 2000 Jun. 23(6):576-81. [QxMD MEDLINE Link].
Glacet-Bernard A, Simon P, Hamelin N, Coscas G, Soubrane G. Translocation of the macula for management of subfoveal choroidal neovascularization: comparison of results in age-related macular degeneration and degenerative myopia. Am J Ophthalmol. 2001 Jan. 131(1):78-89. [QxMD MEDLINE Link].
Gleadall R, Navarro VB, Dejuan E. Macular translocation--what our patients need to know. Insight. 2001 Jul-Sep. 26(3):73-6. [QxMD MEDLINE Link].
Grossniklaus HE, Brooks HL Jr, Sippy BD, Liu P. Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report. Retina. 2002 Dec. 22(6):818-24. [QxMD MEDLINE Link].
Gutierrez Amoros J, Gutierrez Amoros C. [Macular translocation in myopic patient wearing a phakic intraocular lens]. Arch Soc Esp Oftalmol. 2002 Feb. 77(2):99-101. [QxMD MEDLINE Link].
Güven D, Panzan CQ, Humayun MS, De Juan E Jr. Use of rotational sutures for limited retinal translocation: a new technique for superior limited macular translocation. Am J Ophthalmol. 2004 May. 137(5):901-7. [QxMD MEDLINE Link].
Haller JA, Hartranft CD, Fujii GY, Pieramici D, Humayun MS, de Juan E Jr. Limited macular translocation for neovascular maculopathy. Semin Ophthalmol. 2000 Jun. 15(2):81-7. [QxMD MEDLINE Link].
Hamelin N, Glacet-Bernard A, Brindeau C, Mimoun G, Coscas G, Soubrane G. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am J Ophthalmol. 2002 Apr. 133(4):530-6. [QxMD MEDLINE Link].
Ho CL. Macular translocation--an innovative treatment for macular degenerative diseases. Chang Gung Med J. 2000 Nov. 23(11):672-80. [QxMD MEDLINE Link].
Ichibe M, Imai K, Ohta M, Oya Y, Yoshizawa T, Abe H. Simultaneous translocation of the macula and underlying retinal pigment epithelium during macular translocation surgery in a patient with long standing myopic neovascular maculopathy. Br J Ophthalmol. 2003 Mar. 87(3):371-2. [QxMD MEDLINE Link].
Kamei M, Roth DB, Lewis H. Macular translocation with chorioscleral outfolding: an experimental study. Am J Ophthalmol. 2001 Aug. 132(2):149-55. [QxMD MEDLINE Link].
Kamei M, Tano Y, Yasuhara T, et al. Macular translocation with chorioscleral outfolding: 2-year results. Am J Ophthalmol. 2004 Oct. 138(4):574-81. [QxMD MEDLINE Link].
Koh SS, Arroyo J. Macular translocation with 360-degree retinotomy for treatment of exudative age-related macular degeneration. Int Ophthalmol Clin. 2004 Winter. 44(1):73-81. [QxMD MEDLINE Link].
Kubota A, Harino S, Ohji M, Tano Y. Modified technique to create retinal detachment during macular translocation surgery. Am J Ophthalmol. 2003 Jan. 135(1):105-6. [QxMD MEDLINE Link].
Landau K, Messmer E. [Translocation of the retina in senile macular degeneration]. Schweiz Med Wochenschr. 1999 Jan 12. 129(1-2):49-51. [QxMD MEDLINE Link].
Lewis H. Macular translocation with chorioscleral outfolding: a pilot clinical study. Am J Ophthalmol. 2001 Aug. 132(2):156-63. [QxMD MEDLINE Link].
Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol. 1999 Aug. 128(2):135-46. [QxMD MEDLINE Link].
Lin SB, Glaser BM, Gould D, Baudo TA, Lakhanpal RR, Murphy RP. Scleral outfolding for macular translocation. Am J Ophthalmol. 2000 Jul. 130(1):76-81. [QxMD MEDLINE Link].
Machemer R. Macular translocation. Am J Ophthalmol. 1998 May. 125(5):698-700. [QxMD MEDLINE Link].
McLeod D. Foveal translocation for exudative age related macular degeneration. Br J Ophthalmol. 2000 Apr. 84(4):344-5. [QxMD MEDLINE Link].
Morizane Y, Shiraga F, Takasu I, Yumiyama S, Okanouchi T, Ohtsuki H. Selection for inferior limited macular translocation on the basis of distance from the fovea to the inferior edge of the subfoveal choroidal neovascularization. Am J Ophthalmol. 2002 Jun. 133(6):848-50. [QxMD MEDLINE Link].
Ng EW, Fujii GY, Au Eong KG, et al. Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization. Ophthalmology. 2004 Oct. 111(10):1889-93. [QxMD MEDLINE Link].
Ohji M, Fujikado T, Kusaka S, et al. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol. 2001 Dec. 132(6):888-96. [QxMD MEDLINE Link].
Park CH, Toth CA. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 2003 Nov. 136(5):830-5. [QxMD MEDLINE Link].
Pawlak D, Glacet-Bernard A, Papp M, Roquet W, Coscas G, Soubrane G. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol. 2004 May. 137(5):880-7. [QxMD MEDLINE Link].
Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. 2002 Oct. 134(4):560-5. [QxMD MEDLINE Link].
Pieramici DJ, De Juan E Jr, Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2000 Oct. 130(4):419-28. [QxMD MEDLINE Link].
Pieramici DJ, de Juna E Jr. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2001 Jul. 132(1):139-40. [QxMD MEDLINE Link].
Potter MJ, Chang TS, Lee AS, Rai S. Improvement in macular function after retinal translocation surgery in a patient with age-related macular degeneration. Am J Ophthalmol. 2000 Apr. 129(4):547-9. [QxMD MEDLINE Link].
Roig-Melo EA, Afaro DV 3rd, Heredia-Elizondo ML, et al. Macular translocation: histopathologic findings in swine eyes. Eur J Ophthalmol. 2000 Oct-Dec. 10(4):297-303. [QxMD MEDLINE Link].
Roth DB, Estafanous M, Lewis H. Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am J Ophthalmol. 2001 Mar. 131(3):390-2. [QxMD MEDLINE Link].
Sato M, Terasaki H, Ogino N, et al. Strabological findings after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci. 2003 May. 44(5):1939-44. [QxMD MEDLINE Link].
Simon P, Glacet-Bernard A, Coscas G, Soubrane G. [Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia]. J Fr Ophtalmol. 2002 Sep. 25(7):694-700. [QxMD MEDLINE Link].
Sullivan P, Filsecker L, Sears J. Limited macular translocation with scleral retraction suture. Br J Ophthalmol. 2002 Apr. 86(4):434-9. [QxMD MEDLINE Link].
Terasaki H. Rescue of retinal function by macular translocation surgery in age-related macular degeneration and other diseases with subfoveal choroidal neovascularization. Nagoya J Med Sci. 2001 May. 64(1-2):1-9. [QxMD MEDLINE Link].
Terasaki H, Ishikawa K, Suzuki T, Nakamura M, Miyake K, Miyake Y. Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy. Ophthalmology. 2003 Dec. 110(12):2403-8. [QxMD MEDLINE Link].
Terasaki H, Miyake Y, Suzuki T, et al. Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci. 2002 Feb. 43(2):452-7. [QxMD MEDLINE Link].
Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina. 2001. 21(4):293-303. [QxMD MEDLINE Link].
Wirostko WJ, Mittra RA, Rao PK, Borrillo JL, Dev S, Mieler WF. A combination light-pipe, soft-tipped suction, and infusion cannula instrument for macular translocation. Am J Ophthalmol. 2000 Apr. 129(4):549-51. [QxMD MEDLINE Link].
Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology. 2004 Sep. 111(9):1715-24. [QxMD MEDLINE Link].
Lai JC, Lapolice DJ, Stinnett SS, et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol. 2002 Oct. 120(10):1317-24. [QxMD MEDLINE Link].
Kirchhof B. [Macular translocation. Improved prognosis for age-related macular degeneration]. Ophthalmologe. 2002 Mar. 99(3):143. [QxMD MEDLINE Link].
Ichibe M, Yoshizawa T, Funaki S, et al. Severe hypotony after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol. 2002 Jul. 134(1):139-41. [QxMD MEDLINE Link].
Fujikado T, Asonuma S, Ohji M, et al. Reading ability after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol. 2002 Dec. 134(6):849-56. [QxMD MEDLINE Link].
Fujii GY, De Juan E Jr, Zarbin MA, Humayun MS, Au Eong KG, Phillips S. Unintentional transplantation of autologous retinal pigment epithelium during limited macular translocation. Retina. 2001. 21(4):380-2. [QxMD MEDLINE Link].
Cekic O, Ohji M, Hayashi A, Fujikado T, Tano Y. Foveal translocation surgery in age-related macular degeneration. Lancet. 1999 Jul 24. 354(9175):340. [QxMD MEDLINE Link].
Jonas JB, Panda-Jonas S. Retinorhexis in macular translocation. Br J Ophthalmol. 2000 Oct. 84(10):1208. [QxMD MEDLINE Link].
Neugebauer A, Fricke J. [Sensory problems after macular translocation]. Ophthalmologe. 2002 Mar. 99(3):156-9. [QxMD MEDLINE Link].
Oyagi T, Fujikado T, Hosohata J, et al. Foveal sensitivity and fixation stability before and after macular translocation with 360-degree retinotomy. Retina. 2004 Aug. 24(4):548-55. [QxMD MEDLINE Link].
Sterker I, Wolf S, Wiedemann P. Strabological results in patients with macular translocation surgery and counterrotation of the globe as a secondary procedure. Strabismus. 2002 Jun. 10(2):111-7. [QxMD MEDLINE Link].
Terasaki H, Ishikawa K, Niwa Y, et al. Changes in focal macular ERGs after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci. 2004 Feb. 45(2):567-73. [QxMD MEDLINE Link].
Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol. 2004 Jul. 242(7):541-8. [QxMD MEDLINE Link].
Vander JF. Macular translocation. Curr Opin Ophthalmol. 2000 Jun. 11(3):159-65. [QxMD MEDLINE Link].
Wolf S, Lappas A, Weinberger AW, Kirchhof B. Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results. Graefes Arch Clin Exp Ophthalmol. 1999 Jan. 237(1):51-7. [QxMD MEDLINE Link].
Zrenner E. Macular translocation in adult-onset vitelliform macular dystrophy: a therapy to be recommended?. Graefes Arch Clin Exp Ophthalmol. 2004 Jun. 242(6):453-5. [QxMD MEDLINE Link].
de Juan E Jr, Fujii GY. Limited macular translocation. Eye (Lond). 2001 Jun. 15:413-23. [QxMD MEDLINE Link].
de Juan E Jr, Vander JF. Effective macular translocation without scleral imbrication. Am J Ophthalmol. 1999 Sep. 128(3):380-2. [QxMD MEDLINE Link].
Au Eong KG, Fujii GY, Ng EW, Humayun MS, Pieramici DJ, de Juan E Jr. Transient formed visual hallucinations following macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2001 May. 131(5):664-6. [QxMD MEDLINE Link].
Fujii GY, Pieramici DJ, Humayun MS, et al. Complications associated with limited macular translocation. Am J Ophthalmol. 2000 Dec. 130(6):751-62. [QxMD MEDLINE Link].
Kadonosono K, Takeuchi S, Iwata S, Uchio E, Itoh N, Akura J. Macular fold after limited macular translocation treated with scleral shortening release and intravitreal gas. Am J Ophthalmol. 2001 Nov. 132(5):790-2. [QxMD MEDLINE Link].
Kim T, Krishnasamy S, Meyer CH, Toth CA. Induced corneal astigmatism after macular translocation surgery with scleral infolding. Ophthalmology. 2001 Jul. 108(7):1203-8. [QxMD MEDLINE Link].
Buffenn AN, de Juan E, Fujii G, Hunter DG. Diplopia after limited macular translocation surgery. J AAPOS. 2001 Dec. 5(6):388-94. [QxMD MEDLINE Link].
Akyurt A. [Cyclotropia and surgical treatment after macular translocation]. Klin Monbl Augenheilkd. 2002 Jan-Feb. 219(1-2):50-4. [QxMD MEDLINE Link].
Freedman SF, Gearinger MD, Enyedi LB, Holgado S, Toth CA. Measurement of ocular torsion after macular translocation: disc fovea angle and Maddox rod. J AAPOS. 2003 Apr. 7(2):103-7. [QxMD MEDLINE Link].
Freedman SF, Holgado S, Enyedi LB, Toth CA. Management of ocular torsion and diplopia after macular translocation for age-related macular degeneration: prospective clinical study. Am J Ophthalmol. 2003 Oct. 136(4):640-8. [QxMD MEDLINE Link].
Freedman SF, Rojas M, Toth CA. Strabismus surgery for large-angle cyclotorsion after macular translocation surgery. J AAPOS. 2002 Jun. 6(3):154-62. [QxMD MEDLINE Link].
Freedman SF, Seaber JH, Buckley EG, Enyedi LB, Toth CA. Combined superior oblique muscle recession and inferior oblique muscle advancement and transposition for cyclotorsion associated with macular translocation surgery. J AAPOS. 2000 Apr. 4(2):75-83. [QxMD MEDLINE Link].
Fricke J, Neugebauer A. [Surgical eye muscle counter-rotation after macular translocation]. Ophthalmologe. 2002 Mar. 99(3):160-3. [QxMD MEDLINE Link].
Fricke J, Neugebauer A, Nobis H, Bartz-Schmidt KU, Russmann W. Counterrotation of the globe in macular translocation. Graefes Arch Clin Exp Ophthalmol. 2000 Aug. 238(8):664-8. [QxMD MEDLINE Link].
Ohtsuki H, Shiraga F, Hasebe S, Kono R, Yamane T, Fujiwara H. Correction of cyclovertical strabismus induced by limited macular translocation in a case of age-related macular degeneration. Am J Ophthalmol. 2001 Feb. 131(2):270-2. [QxMD MEDLINE Link].
Ohtsuki H, Shiraga F, Morizane Y, Furuse T, Takasu I, Hasebe S. Transposition of the anterior superior oblique insertion as a treatment for excyclotorsion induced from limited macular translocation. Am J Ophthalmol. 2004 Jan. 137(1):125-34. [QxMD MEDLINE Link].
Seaber JH, Machemer R. Adaptation to monocular torsion after macular translocation. Graefes Arch Clin Exp Ophthalmol. 1997 Feb. 235(2):76-81. [QxMD MEDLINE Link].
Stappler T, Stanga P, Groenewald C, El Bably I, Wong D. Measurement of cyclotorsion in a patient following macular translocation surgery using a modified version of the Watzke-Allen test. Retina. 2003 Apr. 23(2):250-2. [QxMD MEDLINE Link].
Bressler NM. Early detection and treatment of neovascular age-related macular degeneration. J Am Board Fam Pract. 2002 Mar-Apr. 15(2):142-52. [QxMD MEDLINE Link].
American Academy of Ophthalmology. Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology. 2000 Dec. 107(12):2314-7. [QxMD MEDLINE Link].
Armbrecht AM, Aspinall PA, Dhillon B. A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br J Ophthalmol. 2004 Oct. 88(10):1270-3. [QxMD MEDLINE Link].
Arnold JJ, Blinder KJ, Bressler NM, et al. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol. 2004 Apr. 137(4):683-96. [QxMD MEDLINE Link].
Augustin AJ. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration]. Krankenpfl J. 2000 Oct. 38(9-10):342-3. [QxMD MEDLINE Link].
Axer-Siegel R, Ehrlich R, Rosenblatt I, et al. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol. 2004 Apr. 122(4):453-9. [QxMD MEDLINE Link].
Axer-Siegel R, Ehrlich R, Yassur Y, et al. Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns. Am J Ophthalmol. 2004 Feb. 137(2):258-64. [QxMD MEDLINE Link].
Azab M, Benchaboune M, Blinder KJ, et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4. Retina. 2004 Feb. 24(1):1-12. [QxMD MEDLINE Link].
Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Arch Ophthalmol. 2003 Sep. 121(9):1253-68. [QxMD MEDLINE Link].
Barnes RM, Gee L, Taylor S, Briggs MC, Harding SP. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'. Eye (Lond). 2004 Aug. 18(8):809-13. [QxMD MEDLINE Link].
Battaglia Parodi M, Da Pozzo S. Hot spots after photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Retina. 2002 Oct. 22(5):671-3. [QxMD MEDLINE Link].
Beck RW. Photodynamic therapy for age-related macular degeneration. Am J Ophthalmol. 2004 Sep. 138(3):513; author reply 513-4. [QxMD MEDLINE Link].
Bessler NM. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients. Retina. 2004 Aug. 24(4):512-20. [QxMD MEDLINE Link].
Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology. 2003 Apr. 110(4):667-73. [QxMD MEDLINE Link].
Blumenkranz MS, Bressler NM, Bressler SB, et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Arch Ophthalmol. 2002 Oct. 120(10):1307-14. [QxMD MEDLINE Link].
Bressler NM. Age related macular degeneration. New hope for a common problem comes from photodynamic therapy. BMJ. 2000 Dec 9. 321(7274):1425-7. [QxMD MEDLINE Link].
Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001 Feb. 119(2):198-207. [QxMD MEDLINE Link].
Bressler NM, Arnold J, Benchaboune M, et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Arch Ophthalmol. 2002 Nov. 120(11):1443-54. [QxMD MEDLINE Link].
Chan WM, Lam DS, Liu DT, Wong TH, Yuen KS. Photodynamic therapy for recurrent myopic choroidal neovascularisation after limited macular translocation surgery. Br J Ophthalmol. 2003 Sep. 87(9):1188-9. [QxMD MEDLINE Link].
Costa RA, Farah ME, Cardillo JA, Belfort R Jr. Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration. Curr Eye Res. 2001 Oct. 23(4):271-5. [QxMD MEDLINE Link].
Desmettre T, Cohen SY, Mordon S. [Photodynamic therapy and age-related macular degeneration in 2000]. J Fr Ophtalmol. 2001 Jan. 24(1):82-93. [QxMD MEDLINE Link].
Donati G, Kapetanios AD, Pournaras CJ. Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration. Semin Ophthalmol. 1999 Mar. 14(1):2-10. [QxMD MEDLINE Link].
Eter N, Vogel A, Inhetvin-Hutter C, Spitznas M. Interval reduction of photodynamic therapy (PDT) in age-related macular degeneration (AMD) is not advantageous. A pilot project [in German]. Ophthalmologe. 2003 Apr. 100(4):314-7. [QxMD MEDLINE Link].
Fine SL. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration. Arch Ophthalmol. 1999 Oct. 117(10):1400-2. [QxMD MEDLINE Link].
Foot B, Foy R, Chakravarthy U, Wormald R. Introduction of photodynamic therapy for the treatment of neovascular age-related macular degeneration: tracking a moving target. Eye (Lond). 2003 Jul. 17(5):583-6. [QxMD MEDLINE Link].
Franks W. Photodynamic therapy for age-related macular degeneration. Age Ageing. 2002 Jan. 31(1):5-6. [QxMD MEDLINE Link].
Gaynes BI, Fiscella RG. Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration. Expert Opin Drug Saf. 2004 Jul. 3(4):345-61. [QxMD MEDLINE Link].
Hamon F, Goeminne P. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD. Semin Ophthalmol. 2001 Dec. 16(4):223-32. [QxMD MEDLINE Link].
Hopley C, Salkeld G, Wang JJ, Mitchell P. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Br J Ophthalmol. 2004 Apr. 88(4):450-4. [QxMD MEDLINE Link].
Jaakkola A. [Photodynamic therapy of age-related macular degeneration]. Duodecim. 2002. 118(8):813-9. [QxMD MEDLINE Link].
Jin C, Ge J, Zhou S, et al. Photodynamic therapy for age-related macular degeneration. Yan Ke Xue Bao. 2004 Sep. 20(3):158-62. [QxMD MEDLINE Link].
Karacorlu M, Karacorlu S, Ozdemir H. Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration. Jpn J Ophthalmol. 2003 Nov-Dec. 47(6):595-8. [QxMD MEDLINE Link].
Kubicka-Trzaska A, Starzycka M. [Photodynamic therapy with indocyanine green for choroidal neovascularization caused by age-related macular degeneration--a preliminary record]. Klin Oczna. 2003. 105(6):351-4. [QxMD MEDLINE Link].
Messmer KJ, Abel SR. Verteporfin for age-related macular degeneration. Ann Pharmacother. 2001 Dec. 35(12):1593-8. [QxMD MEDLINE Link].
Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep. 117(9):1161-73. [QxMD MEDLINE Link].
Piermarocchi S, Lo Giudice G, Sartore M, et al. Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration. Am J Ophthalmol. 2002 Apr. 133(4):572-5. [QxMD MEDLINE Link].
Rechtman E, Ciulla TA, Criswell MH, Pollack A, Harris A. An update on photodynamic therapy in age-related macular degeneration. Expert Opin Pharmacother. 2002 Jul. 3(7):931-8. [QxMD MEDLINE Link].
Rubin GS, Bressler NM. Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4. Retina. 2002 Oct. 22(5):536-44. [QxMD MEDLINE Link].
Sawa M, Chan WM, Ohji M, et al. Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy. Am J Ophthalmol. 2003 Sep. 136(3):560-3. [QxMD MEDLINE Link].
Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol. 2000 Nov-Dec. 45(3):195-214. [QxMD MEDLINE Link].
Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep. 117(9):1177-87. [QxMD MEDLINE Link].
Scorolli L, Scalinci SZ, Limoli PG, et al. [Photodynamic therapy for age related macular degeneration with and without antioxidants]. Can J Ophthalmol. 2002 Dec. 37(7):399-404. [QxMD MEDLINE Link].
Sharma S. Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Can J Ophthalmol. 2001 Feb. 36(1):7-10. [QxMD MEDLINE Link].
Sharma S, Bakal J, Oliver-Fernandez A, Blair J. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study. Arch Ophthalmol. 2004 Jun. 122(6):853-6. [QxMD MEDLINE Link].
Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2001 Nov. 108(11):2051-9. [QxMD MEDLINE Link].
Sivaprasad S, Hammond CJ, Jackson H. Photodynamic therapy for age-related macular degeneration. Eye (Lond). 2005 Sep. 19(9):1027-8. [QxMD MEDLINE Link].
Smith DH, Fenn P, Drummond M. Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case. Br J Ophthalmol. 2004 Sep. 88(9):1107-12. [QxMD MEDLINE Link].
Blinder KJ, Bradley S, Bressler NM, et al. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol. 2003 Sep. 136(3):407-18. [QxMD MEDLINE Link].
van den Bergh H, Ballini JP, Sickenberg M. On the selectivity of photodynamic therapy of choroidal neovascularization associated with age-related macular degeneration. J Fr Ophtalmol. 2004 Jan. 27(1):75-8. [QxMD MEDLINE Link].
van den Bergh H. Photodynamic therapy of age-related macular degeneration: History and principles. Semin Ophthalmol. 2001 Dec. 16(4):181-200. [QxMD MEDLINE Link].
Yassur Y, Weinberger D, Goldstein M, Loewenstein A. [Photodynamic therapy in age-related macular degeneration]. Harefuah. 2000 Sep. 139(5-6):220-3. [QxMD MEDLINE Link].
Wykrota H, Gierek-Lapinska A. [Photodynamic therapy in age-related macular degeneration--results of one year observation]. Klin Oczna. 2002. 104(3-4):239-43. [QxMD MEDLINE Link].
Wu L, Murphy RP. Photodynamic therapy: a new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration. Curr Opin Ophthalmol. 1999 Jun. 10(3):217-20. [QxMD MEDLINE Link].
Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2003. CD002030. [QxMD MEDLINE Link].
Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2001. CD002030. [QxMD MEDLINE Link].
Wormald R, Evans J, Smeeth L. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2000. CD002030. [QxMD MEDLINE Link].
Wenkstern A, Stokes J. Photodynamic therapy in age-related macular degeneration: missing information. Age Ageing. 2003 May. 32(3):357-9. [QxMD MEDLINE Link].
Verteporfin Roundtable 2000 and 2001 Participants. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina. 2002 Feb. 22(1):6-18. [QxMD MEDLINE Link].
Torron Fernandez-Blanco C, Perez Olivan S, et al. [Photodynamic therapy for choroidal neovascularization not caused by age related macular degeneration or pathologic myopia]. Arch Soc Esp Oftalmol. 2003 Sep. 78(9):471-6. [QxMD MEDLINE Link].
Tholen AM, Bernasconi PP, Fierz AB, Messmer EP. [Reading ability after photodynamic therapy (PDT) for age-related macular degeneration (AMD) and for high myopia]. Ophthalmologe. 2003 Jan. 100(1):28-32. [QxMD MEDLINE Link].
Sternberg P Jr, Lewis H. Photodynamic therapy for age-related macular degeneration: a candid appraisal. Am J Ophthalmol. 2004 Mar. 137(3):483-5. [QxMD MEDLINE Link].
Soubrane G, Kuhn D, Coscas G. [Indications for photodynamic therapy in age-related macular degeneration]. J Fr Ophtalmol. 2004 Jan. 27(1):79-80. [QxMD MEDLINE Link].
Soubrane G, Bressler NM. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy. Br J Ophthalmol. 2001 Apr. 85(4):483-95. [QxMD MEDLINE Link].
Samkoe KS, Cramb DT. Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J Biomed Opt. 2003 Jul. 8(3):410-7. [QxMD MEDLINE Link].
Ruiz-Moreno JM, Montero JA. Sequential combined therapy for treatment of choroidal neovascularization in age-related macular degeneration: photodynamic therapy and thermal laser photocoagulation. Eur J Ophthalmol. 2003 Oct. 13(8):681-6. [QxMD MEDLINE Link].
Theodossiadis GP, Panagiotidis D, Georgalas IG, Moschos M, Theodossiadis PG. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2003 Jan. 241(1):13-8. [QxMD MEDLINE Link].
Porter T, Nesbitt P. Psychosocial implications of clinical trials on patients with age-related macular degeneration and pathologic myopia as seen in the photodynamic therapy trials. Insight. 2001 Apr. 26(2):40-3. [QxMD MEDLINE Link].
Meads C, Salas C, Roberts T, Moore D, Fry-Smith A, Hyde C. Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess. 2003. 7(9):v-vi, 1-98. [QxMD MEDLINE Link].
Mandal N, Chisholm IH. Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne). Br J Ophthalmol. 2002 Jan. 86(1):118-9. [QxMD MEDLINE Link].
Japanese Age-Related Macular Degeneration Trial (JAT) Study Group. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2003 Dec. 136(6):1049-61. [QxMD MEDLINE Link].
Isola V, Pece A, Brancato R. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Retina. 2004 Aug. 24(4):618-20. [QxMD MEDLINE Link].
Hopley C, Salkeld G, Mitchell P. Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration. Br J Ophthalmol. 2004 Aug. 88(8):982-7. [QxMD MEDLINE Link].
Greiner RA. Cost of care for patients with age-related macular degeneration in Switzerland and cost-effectiveness of treatment with verteporfin therapy. Semin Ophthalmol. 2001 Dec. 16(4):218-22. [QxMD MEDLINE Link].
Gierek-Lapinska A, Wykrota H, Trzciakowski K. [New methods of treatment of age-related macular degeneration. Photodynamic therapy. Part I]. Klin Oczna. 2002. 104(3-4):276-82. [QxMD MEDLINE Link].
Ghazi NG, Jabbour NM, De La Cruz ZC, Green WR. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina. 2001. 21(5):478-86. [QxMD MEDLINE Link].
Cohen SY, Bulik A, Tadayoni R, Quentel G. Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration. Br J Ophthalmol. 2003 Aug. 87(8):977-9. [QxMD MEDLINE Link].
Bressler NM. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2002 Jan. 133(1):168-9. [QxMD MEDLINE Link].
Bressler SB, Pieramici DJ, Koester JM, Bressler NM. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6. Arch Ophthalmol. 2004 Mar. 122(3):325-9. [QxMD MEDLINE Link].
TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999 Oct. 117(10):1329-45. [QxMD MEDLINE Link].
Ruiz-Oliva F, Cortés J. Verteporfin in Photodynamic Therapy (VIP) Study group. Ophthalmology. 2002 Jun. 109(6):1043; author reply 1043-4. [QxMD MEDLINE Link].
Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology. 2001 May. 108(5):841-52. [QxMD MEDLINE Link].
Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001 May. 131(5):541-60. [QxMD MEDLINE Link].
Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol. 2004 Mar. 88(3):344-7. [QxMD MEDLINE Link].
Ahuja RM, Benner JD, Schwartz JC, Butler JW, Steidl SM. Efficacy of transpupillary thermotherapy (TTT) in the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol. 2001 Jun. 16(2):81-5. [QxMD MEDLINE Link].
Auer C, Tao Tran V, Herbort CP. Transpupillary thermotherapy for occult subfoveal neovessels in age-related macular degeneration: importance of patient pigmentation for the determination of laser settings. Klin Monbl Augenheilkd. 2002 Apr. 219(4):250-3. [QxMD MEDLINE Link].
Desmettre T, Maurage CA, Mordon S. Transpupillary thermotherapy (TTT) with short duration laser exposures induce heat shock protein (HSP) hyperexpression on choroidoretinal layers. Lasers Surg Med. 2003. 33(2):102-7. [QxMD MEDLINE Link].
Friberg TR, Pandya A, Nazari K. Transpupillary thermotherapy (TTT) for age-related macular degeneration. Semin Ophthalmol. 2001 Jun. 16(2):70-80. [QxMD MEDLINE Link].
Mueller AJ, Ulbig M, Kampik A. TTT for occult CNV: check the power!. Br J Ophthalmol. 2002 Oct. 86(10):1194. [QxMD MEDLINE Link].
Newsom R. TTT and CNV. Br J Ophthalmol. 2001 Oct. 85(10):1268-9. [QxMD MEDLINE Link].
Newsom RS, McAlister JC, Saeed M, McHugh JD. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation. Br J Ophthalmol. 2001 Feb. 85(2):173-8. [QxMD MEDLINE Link].
Park CH, Duker JS, Mainster MA, Puliafito CA, Reichel E. Transpupillary thermotherapy (TTT) of occult choroidal neovascularization: a retrospective, noncomparative case series of fifty-seven eyes. Semin Ophthalmol. 2001 Jun. 16(2):66-9. [QxMD MEDLINE Link].
Verma L, Sinha A, Nainiwal S, Tewari HK. Transpupillary thermo therapy for the treatment of choroidal neovascularisation secondary to age related macular degeneration in Indian eyes. Indian J Ophthalmol. 2004 Mar. 52(1):86-7; author reply 87. [QxMD MEDLINE Link].
Verma L, Tewari HK, Nainiwal S, Ravindranathan J. Transpupillary thermotherapy in subfoveal choroidal neovascular membrane secondary to age-related macular degeneration. Indian J Ophthalmol. 2004 Mar. 52(1):35-40. [QxMD MEDLINE Link].
Ciulla TA, Danis RP, Criswell M, Pratt LM. Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy. Expert Opin Investig Drugs. 1999 Dec. 8(12):2173-2182. [QxMD MEDLINE Link].
Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology. 2003 May. 110(5):979-86. [QxMD MEDLINE Link].
Ciulla TA, Danis RP, Klein SB, et al. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial. Am J Ophthalmol. 2002 Dec. 134(6):905-6. [QxMD MEDLINE Link].
Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2004 Oct 18. CD004004. [QxMD MEDLINE Link].
Ergun E, Stur M. TTT and CNV. Br J Ophthalmol. 2001 Aug. 85(8):1013. [QxMD MEDLINE Link].
Hammerstein W, Gebauer HJ. [Familial nystagmus and hypoplasia of the macular in reciprocal, balanced translocation 5/16]. Fortschr Ophthalmol. 1989. 86(6):718-21. [QxMD MEDLINE Link].
Takeuchi M, Itagaki T, Takahashi K, Ohkuma H, Uyama M. [Changes in the intermediate stage of retinal degeneration after intravitreal injection of ornithine]. Nippon Ganka Gakkai Zasshi. 1993 Jan. 97(1):17-28. [QxMD MEDLINE Link].
Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003 Oct 15. 290 (15):2057-60. [QxMD MEDLINE Link].
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol. 1991 Sep. 109 (9):1220-31. [QxMD MEDLINE Link].
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol. 1999 Oct. 117 (10):1329-45. [QxMD MEDLINE Link].
Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001 May. 131 (5):541-60. [QxMD MEDLINE Link].
Yancopoulos GD. Clinical application of therapies targeting VEGF. Cell. 2010 Oct 1. 143 (1):13-6. [QxMD MEDLINE Link].
Ferrara N. VEGF-A: a critical regulator of blood vessel growth. Eur Cytokine Netw. 2009 Dec. 20 (4):158-63. [QxMD MEDLINE Link].
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5. 355 (14):1419-31. [QxMD MEDLINE Link].
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5. 355 (14):1432-44. [QxMD MEDLINE Link].
Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, et al. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology. 2011 May. 118 (5):831-9. [QxMD MEDLINE Link].
Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008 Feb. 145 (2):239-248. [QxMD MEDLINE Link].
Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology. 2009 Sep. 116 (9):1731-9. [QxMD MEDLINE Link].
Singer MA, Awh CC, Sadda S, Freeman WR, Antoszyk AN, Wong P, et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2012 Jun. 119 (6):1175-83. [QxMD MEDLINE Link].
CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011 May 19. 364 (20):1897-908. [QxMD MEDLINE Link].
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012 Jul. 119 (7):1388-98. [QxMD MEDLINE Link].
IVAN Study Investigators, Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012 Jul. 119 (7):1399-411. [QxMD MEDLINE Link].
Economides AN, Carpenter LR, Rudge JS, Wong V, Koehler-Stec EM, Hartnett C, et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat Med. 2003 Jan. 9 (1):47-52. [QxMD MEDLINE Link].
Holash J, Davis S, Papadopoulos N, Croll SD, Ho L, Russell M, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. 2002 Aug 20. 99 (17):11393-8. [QxMD MEDLINE Link].
Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, et al. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology. 2011 Jun. 118 (6):1098-106. [QxMD MEDLINE Link].
Stewart MW, Rosenfeld PJ. Predicted biological activity of intravitreal VEGF Trap. Br J Ophthalmol. 2008 May. 92 (5):667-8. [QxMD MEDLINE Link].
Brown DM, Heier JS, Ciulla T, Benz M, Abraham P, Yancopoulos G, et al. Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology. 2011 Jun. 118 (6):1089-97. [QxMD MEDLINE Link].